Trizivir Vs. Kaletra y Combivir para la Prevención de la transmisión de madre a hijo del VIH

Categoría Estudio primario
Año 2005
Cargando información sobre las referencias
Anti-HIV drug regimens have dramatically improved the rates of prevention of mother-to-child transmission (MTCT) of HIV in developed countries. However, little is known of the effectiveness of such regimens in developing countries, such as Botswana. This study will determine whether Trizivir (TZV), a single pill containing abacavir sulfate, lamivudine, and zidovudine (ABC/3TC/ZDV), or lopinavir/ritonavir (LPV/r) and lamivudine/zidovudine (3TC/ZDV) is more effective in reducing HIV-1 viral load and preventing MTCT among HIV infected pregnant women in Botswana.
Epistemonikos ID: 89296bcded0c54a981b0333453a5a4650e808881
First added on: Dec 21, 2013